1-4 of 4
Takumi Ito
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Aromatase is a novel neosubstrate of cereblon responsible for immunomodulatory drug–induced thrombocytopenia

Taro Tochigi, Toshihiro Miyamoto, Kiwamu Hatakeyama, Teppei Sakoda, Daisuke Ishihara, Hidetoshi Irifune, Takahiro Shima, Koji Kato, Takahiro Maeda, Takumi Ito, Hiroshi Handa, Koichi Akashi, Yoshikane Kikushige
Journal: Blood
Blood (2020) 135 (24): 2146–2158.
https://doi.org/10.1182/blood.2019003749
Published: 2020
Includes: Supplemental data
Journal Articles

Combined Inhibition of HDAC and AKT As a Strategy to Overcome Multi-Drug Resistance in Patients with Multiple Myeloma

Mitsuhito Hirano, MD, Yoichi Imai, MD PhD, Takahiko Murayama, PhD, Kota Sato, MD PhD, Junichi Yamamoto, PhD, Takumi Ito, PhD, Muneyoshi Futami, MD PhD, Masaki Ri, Hiroshi Yasui, MD PhD, Noriko Gotoh, MD, Shinsuke Iida, MD PhD, Tadao Ishida, MD PhD, Hiroshi Handa, MD PhD, Arinobu Tojo, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4325.
https://doi.org/10.1182/blood-2019-122662
Published: 2019
Journal Articles

Upregulation of PD-L1 on Myeloma Cells By Immunomodulatory Agents Potentiates the Effect of Durvalumab

Mariko Ishibashi, PhD, Junichi Yamamoto, PhD, Takumi Ito, PhD, Hiroshi Handa, MD PhD, Koiti Inokuchi, MD PhD, Hidemi Takahashi, MD PhD, Hideto Tamura, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4439.
https://doi.org/10.1182/blood-2018-99-112322
Published: 2018
Journal Articles

Lenalidomide Effectively Induces Philadelphia-Chromosome Positive ALL Cells into Apoptosis in Synergy with Tyrosine Kinase Inhibitor

Daisuke Harama, MD PhD, Minori Tamai, MD PhD, Takeshi Inukai, MD, PhD, Kumiko Goi, MD, PhD, Takashi Yahata, PhD, Kiyoshi Ando, Takumi Ito, Hiroshi Handa, MD PhD, Kanji Sugita, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 1060.
https://doi.org/10.1182/blood.V128.22.1060.1060
Published: 2016